James George Chopas
CIK 1836430 · VP/Chief Accounting Officer · last filed 2026-05-14
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$0
Companies
2
Total Filings
33
Lifetime Open-Market Net
-$382.7K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Apellis Pharmaceuticals, Inc. (APLS) Delisted | VP/Chief Accounting Officer | 8,075 | $41.03 | $331.3K | -$374.9K | 30 | 2026-05-14 |
| Radius Health, Inc. (RDUS) Delisted | Principal Finance Accounting | 6,701 | $30.00 | $201.0K | -$7.7K | 3 | 2021-03-09 |
Recent Filings · Page 2 of 4
33 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-01-23 | Apellis Pharmaceuticals, Inc. (APLS) Delisted | Sell (S) | −1,096 | -$33.3K | EDGAR |
| 2025-01-21 | Apellis Pharmaceuticals, Inc. (APLS) Delisted | Mixed | +11,876 | -$21.4K | EDGAR |
| 2025-01-14 | Apellis Pharmaceuticals, Inc. (APLS) Delisted | Sell (S) | −783 | -$22.5K | EDGAR |
| 2024-09-17 | Apellis Pharmaceuticals, Inc. (APLS) Delisted | Sell (S) | −192 | -$7.0K | EDGAR |
| 2024-09-04 | Apellis Pharmaceuticals, Inc. (APLS) Delisted | Sell (S) | −550 | -$21.7K | EDGAR |
| 2024-03-18 | Apellis Pharmaceuticals, Inc. (APLS) Delisted | Sell (S) | −184 | -$10.4K | EDGAR |
| 2024-01-23 | Apellis Pharmaceuticals, Inc. (APLS) Delisted | Sell (S) | −1,061 | -$69.0K | EDGAR |
| 2024-01-17 | Apellis Pharmaceuticals, Inc. (APLS) Delisted | Mixed | +7,448 | -$57.7K | EDGAR |
| 2023-10-24 | Apellis Pharmaceuticals, Inc. (APLS) Delisted | Sell (S) | −132 | -$6.1K | EDGAR |
| 2023-09-18 | Apellis Pharmaceuticals, Inc. (APLS) Delisted | Grant (A) | +2,500 | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.